AKEBIA THERAPEUTICS, INC. Available-for-sale Securities, Gross Realized Gains
AKEBIA THERAPEUTICS, INC. (AKBA) reported Available-for-sale Securities, Gross Realized Gains of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2018-11-08
- AKEBIA THERAPEUTICS, INC. available-for-sale securities, gross realized gains for the quarter ending 2018-09-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. available-for-sale securities, gross realized gains for the quarter ending 2018-06-30 was $0.00.
- AKEBIA THERAPEUTICS, INC. available-for-sale securities, gross realized gains for the quarter ending 2018-03-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. available-for-sale securities, gross realized gains for the quarter ending 2017-12-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. available-for-sale securities, gross realized gains for fiscal 2017 was $0.00.
- AKEBIA THERAPEUTICS, INC. available-for-sale securities, gross realized gains for fiscal 2016 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 6 month | Available-for-sale Securities, Gross Realized Gains 9 month | Available-for-sale Securities, Gross Realized Gains 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $0.00 derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | $0.00 derived: sum of 3 quarters · filed 2018-08-08 | $0.00 derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-05-09 | $0.00 derived: sum of 3 quarters · filed 2018-11-08 | $0.00 derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 derived: sum of 3 quarters · filed 2018-11-08 | $0.00 10-K · filed 2018-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |